AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU
December 19, 2022 at 02:54 AM EST
The Anglo-Swedish pharma giant said the Committee for Medicinal Products for Human Use of the European Medicines Agency based its opinion on results from the Himalaya Phase 3 trial, and results from the Poseidon Phase 3 trial.
